SECY-14-0002, SECY-22-0028: Enclosure 6 - Disposition of Activities Identified in SECY-14-0002 and SECY-14-0143

From kanterella
Jump to navigation Jump to search
SECY-22-0028: Enclosure 6 - Disposition of Activities Identified in SECY-14-0002 and SECY-14-0143
ML21228A248
Person / Time
Issue date: 04/01/2022
From:
NRC/SECY
To:
Noto P
Shared Package
ML21228A118 List:
References
SECY-14-0002, SECY-14-0143 SECY-22-0028
Download: ML21228A248 (4)


Text

Enclosure 6 Disposition of Activities Identified in SECY-14-0002 and SECY-14-0143 This enclosure documents the disposition of the activities identified in SECY-14-0002, Plan for Updating the U.S. Nuclear Regulatory Commissions Cost-Benefit Guidance, dated January 2, 2014 (Agencywide Documents Access and Management System (ADAMS) Accession No. ML13274A519) and SECY-14-0143, Regulatory Gap Analysis of the Nuclear Regulatory Commissions Cost Benefit Guidance and Practices, dated December 16, 2014 (ADAMS Accession No. ML14280A426).

Topic Staff Disposition SECY-14-0002, Plan for Updating the Cost-Benefit Guidance Perform a Regulatory Gap Analysis SECY-14-0143, Regulatory Gap Analysis of the Nuclear Regulatory Commissions Cost Benefit Guidance and Practices, dated December 16, 2014 (ADAMS Accession No. ML14280A426)

Update Replacement Energy Guidance NUREG-2242, Replacement Energy Cost Estimates for Nuclear Power Plants:

2020-2030, dated June 2021 (ADAMS Accession No. ML21174A176)

Appendix L, Replacement Energy Cost Estimates, is being developed and will be submitted to the Commission for review and approval.

Update Dollar per Person-Rem Conversion Factor Guidance NUREG-1530, Revision 1, Reassessment of the NRCs Dollar Per Person-Rem Conversion Factor Policy,1 (ADAMS Accession No. ML16147A392)

(SECY-17-0017)

Appendix K, Monetary Valuation of Nonfatal Cancer Risk for Use in Cost-Benefit Analysis, is being developed and will be submitted to the Commission for review and approval.

Qualitative Factors SECY-14-0087, Qualitative Consideration of Factors in the Development of Regulatory Analyses and Backfit Analyses, dated August 14, 2014 (ADAMS Accession No. ML14127A458)

Appendix A, Qualitative Factors Assessment Tools, in accordance with SRM-SECY-14-0087, Qualitative Consideration of Factors in the Development of Regulatory Analyses and 1 SECY-17-0017, Proposed Revision to NUREG-1530, Reassessment of the NRCs Dollar Per Person-Rem Conversion Factor Policy, dated January 30, 2017 (ADAMS Accession No. ML16147A293, package)

2 Backfit Analyses, dated March 4, 2015 (ADAMS Accession No. ML15063A568)

Cumulative Effects of Regulation NUREG/BR-0058, Revision 5, Regulatory Analysis Guidelines of the U.S. Nuclear Regulatory Commission2 (ADAMS Accession No. ML19261A278) and associated appendices (SECY-20-0008)

Disposition of Near-Term Task Force Recommendation 1 NUREG/BR-0058, Revision 5, Regulatory Analysis Guidelines of the U.S. Nuclear Regulatory Commission (ADAMS Accession No. ML19261A278)Treatment of Industry Initiatives Section (SECY-20-0008)

Price-Anderson Act This is being addressed in a separate effort.

No policy issues were identified while preparing the December 31, 2021 report to Congress that would require Commission approval. The draft report was provided to the Commission on August 2, 2021.

Phase 1 - Consolidating Cost-Benefit Guidance and Administrative Changes NUREG/BR-0058, Revision 5, Regulatory Analysis Guidelines of the U.S. Nuclear Regulatory Commission (ADAMS Accession No. ML19261A278) (SECY-20-0008)

Phase 2 -

Policy Issues Consequence and Probabilistic Methodology Review MACCS2 Implementation Periodic Review of Cost-Benefit Guidance No additional policy issues were identified during this update that would require Commission approval.

The current practice for assessing consequences of future potential accidents is described in Appendix H, Severe Accident Risk Analysis, (ADAMS Accession No. ML21228A246) to NUREG/BR-0058, Revision 5.

MACCS2 Implementation is ongoing. The User Guide, Theory Manual, and Input Parameter Guidance have been updated.

MAACS code version 4.1 was recently released (https://maccs.sandia.gov/).

Following issuance of NUREG/BR-0058, Revision 5, the staff will update this guidance as needed, unless specific timeframes are identified (i.e., NUREG-2242 and NUREG-1530).

SECY-14-0143, Regulatory Gap Analysis Power Reactor Substantial Safety Enhancement Screen NUREG/BR-0058, Revision 5, Regulatory Analysis Guidelines of the U.S. Nuclear Regulatory Commission (ADAMS Accession No. ML19261A278) (SECY-20-0008) 2 SECY-20-0008, Draft Final NUREG/BR-0058, Regulatory Analysis Guidelines of the U.S. Nuclear Regulatory Commission, dated January 28, 2020 (ADAMS Accession No. ML19261A277, package)

3 Time Horizon NUREG/BR-0058, Revision 5, Regulatory Analysis Guidelines of the U.S. Nuclear Regulatory Commission (ADAMS Accession No. ML19261A278) (SECY-20-0008)

Sensitivity Analyses NUREG/BR-0058, Revision 5, Regulatory Analysis Guidelines of the U.S. Nuclear Regulatory Commission (ADAMS Accession No. ML19261A278)

(SECY-20-0008)

Appendix C, Treatment of Uncertainty, (ADAMS Accession No. ML19261A285) to NUREG/BR-0058, Revision 5 (SECY-20-0008)

Changes in Variables over Time RG 4.2, Revision 3, Preparation of Environmental Reports for Nuclear Power Stations, dated September 2018 (ADAMS Accession No. ML18071A400)

Terminology and Other Minor Differences NUREG/BR-0058, Revision 5, Regulatory Analysis Guidelines of the U.S. Nuclear Regulatory Commission (ADAMS Accession No. ML19261A278)

(SECY-20-0008)

NUREG-1409, Revision 1, Backfitting Guidelines,3 (ADAMS Accession No ML21006A433) (SECY-21-0037)

Quantification of Benefits Appendix A, Qualitative Factors Assessment Tools, (ADAMS Accession No. ML19261A282) to NUREG/BR-0058, Revision 5 (SECY-20-0008)

Treatment of Uncertainty Appendix C, Treatment of Uncertainty, (ADAMS Accession No. ML19261A285) to NUREG/BR-0058, Revision 5 (SECY 0008)

Use of Probabilistic Risk Assessment and Other Studies in Regulatory Analyses Appendix H, Severe Accident Risk Analysis, (ADAMS Accession No. ML21228A246) to NUREG/BR-0058, Revision 5 The Consideration of Distributive Impacts and Equity in NRC Cost-Benefit Analyses This is being addressed in the Environmental Justice SECY paper responding to SRM-M210218B, Staff Requirements - Briefing on Equal Employment Opportunity, Affirmative Employment, and Small Business, 10:00 A.M., Thursday, February 18, 2021, Video Conference Meeting (Open to Public via Webcast and Teleconference), dated April 23, 2021 (ADAMS Accession No. ML21113A070) 3 SECY-21-0037, NUREG-1409, Revision 1, Backfitting Guidelines, dated April 15, 2021 (ADAMS Accession No. ML21006A431, package)

4 The Impact of Regulatory Decisionmaking on Offsite Properties with Iconic Value Impact on Critical Infrastructure Addressed in NRC reviews during plant licensing. For future regulatory actions, impacts to these properties and critical infrastructure are addressed on a case-by-case basis in the Other Considerations attribute as defined in NUREG/BR-0058, Revision 5, Regulatory Analysis Guidelines of the U.S. Nuclear Regulatory Commission (ADAMS Accession No. ML19261A278).

Additional guidance for addressing these topics was deemed unnecessary.